The clinical benefits of IDegLira in DUAL VII were achieved while using a simple regimen with fewer injections and dose adjustments compared with basal-bolus therapy

E. M. Miller, E. Jodar,K. Khunti,D. Sugimoto, P. Orsy,M. F. Ranthe,A. Viljoen

DIABETOLOGIA(2018)

引用 2|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要